CDKN2A/P16 expression in mycosis fungoides

被引：0
|
作者：
Fargnoli, MC
Chimenti, S
Stanta, G
Bonin, S
Amantea, A
Felli, A
Peris, K
机构：
[1] UNIV AQUILA,DEPT DERMATOL,I-67100 LAQUILA,ITALY
[2] UNIV TRIESTE,DEPT PATHOL,I-34127 TRIESTE,ITALY
[3] INT CTR GENET ENGN & BIOTECHNOL PADRICIANO,TRIESTE,ITALY
[4] IRCCS,IST SAN GALLICANO,ROME,ITALY
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1997年 / 109卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：487 / 487
页数：1
相关论文
共 50 条
  • [41] MTAP and p16 Immunohistochemistry as Markers for CDKN2A/B Loss in Meningiomas
    Ozkizilkaya, H.
    Ozkizilkaya, H.
    Ogunbona, O. Basit
    Toruner, G.
    Aung, P.
    Esquenazi, Y.
    DeMonte, F.
    Ballester, L.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 546 - 546
  • [42] Loss of p16 (CDKN2A) Expression Is Rare in Dedifferentiated Liposarcoma and Does Not Promote Tumor Progression
    Kang, Y.
    Horvai, A. E.
    LABORATORY INVESTIGATION, 2014, 94 : 19A - 19A
  • [43] CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure
    Eeva Kettunen
    Sauli Savukoski
    Kaisa Salmenkivi
    Tom Böhling
    Esa Vanhala
    Eeva Kuosma
    Sisko Anttila
    Henrik Wolff
    BMC Cancer, 19
  • [44] Methylation: A major cause of p16/CDKN2A inactivation in uveal melanoma
    Metzelaar, JW
    van der Velden, PA
    Gruis, NA
    Hurks, HM
    Ksander, BR
    Jager, MJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S184 - S184
  • [45] CDKN2A (p16(INK4A)) somatic and germline mutations
    SmithSorensen, B
    Hovig, E
    HUMAN MUTATION, 1996, 7 (04) : 294 - 303
  • [46] CDKN2A/p16, RB and CDK4 alterations in osteosarcoma
    Nielsen, GP
    Burns, K
    Rosenberg, AE
    Louis, DN
    MODERN PATHOLOGY, 1998, 11 (01) : 13A - 13A
  • [47] p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances
    Geyer, Lucas
    Wolf, Thibaut
    Chenard, Marie-Pierre
    Cebula, Helene
    Schott, Roland
    Noel, Georges
    Guerin, Eric
    Pencreach, Erwan
    Reita, Damien
    Entz-Werle, Natacha
    Lhermitte, Benoit
    CANCERS, 2023, 15 (05)
  • [48] Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas
    Dacic, Sanja
    Kothmaier, Hannelore
    Land, Stephanie
    Shuai, Yongli
    Halbwedl, Iris
    Morbini, Patrizia
    Murer, Bruno
    Comin, Camilla
    Galateau-Salle, Francoise
    Demirag, Funda
    Zeren, Handan
    Attanoos, Richard
    Gibbs, Alan
    Cagle, Philip
    Popper, Helmut
    VIRCHOWS ARCHIV, 2008, 453 (06) : 627 - 635
  • [49] CDKN2A/p16 inactivation is related to pituitary adenoma type and size
    Seemann, N
    Kuhn, D
    Wrocklage, C
    Keyvani, K
    Hackl, W
    Buchfelder, M
    Fahlbusch, R
    Paulus, W
    JOURNAL OF PATHOLOGY, 2001, 193 (04): : 491 - 497
  • [50] P15 and p16 are not involved in transformation of mycosis fungoides
    Ahnhudt, C
    Lukowsky, A
    Gellrich, S
    Sterry, W
    Muche, JM
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 558 - 558
12345